Get 12 weeks of The Spectator in print and online for just £12.

And we'll give you a £20 £20, Amazon Give Voucher, absolutely free.

Go to spectator.com.uk forward slash voucher.

Hello and welcome to Coffee House Shots, Spectator's Daily Politics Podcast. I'm Katie Balls and I'm joined by Fraser Nelson and James Forsyfe. So the UK's vaccination program has received another boost. The NovaVax vaccine has successfully completed its phase-free UK trials. And this means that while this is not immediate, the data will now go to the MHRA,

and we could in the coming months have another vaccine that we have a mass order in in terms of

60 million doses. James, this seems like another good news story in terms of the UK's vaccine

efforts. But given that we're talking about how these vaccines might not be here with us to the

second half of the year, how does it actually change the current picture? Well, I think you can never

have too much vaccine. The whole world is going to need to be vaccinated. But Tony Blair argument

that Vara somewhere is Vara's going to be anywhere has some truth to it. You look at this hotel

quarantine policy announced

this week. I think it shows you that until you vaccinated the kind of global population,

because of a transmissibility of this virus, people aren't going to be totally confident that

you've dealt with the situation. So if you can build more vaccine here, even once the UK population has been vaccinated, there will be lots and lots of uses for it.

I think this is also an interesting point here because what we are seeing is the emergence of a new industry in the UK, the kind of vaccine manufacturing.

It's worth of remembering that in the beginning of this crisis, the UK had no ability at all to produce vaccine on a commercial scale.

You've now got multiple vaccines being manufactured in this country.

And I think there is an element that this is going to slightly change Tory thinking,

I mean in two ways.

First of all, generally British industrial strategy

has been about propping up losers rather than picking winners. This is a rare example of where

government has worked to link up academia with companies, helped fund the developments of factories,

...